Over 100 million HPV Tests and counting

Over 100 million women screened for HPV with QIAGEN solutions. We are proud to be a partner in fighting cervical cancer with our HPV testing solutions. Learn about our commitment to screening 100 million more.

QIAGEN is a leader in cervical cancer screening. See how our customers are using QIAGEN HPV solutions.

See how the digene HC2 HPV test is the gold standard in Ivana Hojsikova’s work.

Jose Eduardo Levi uses digene HC2 and believes HPV testing should be available for all women worldwide.

In Russia, digene HC2’s high sensitivity is why this is their test of choice.

Murat Gueltekin describes the impact of the digene HC2 test on Turkey’s cervical cancer screening program.

Share your HC2 story and get an exclusive QIAGEN T-shirt while supplies last.* Your story may get featured here!

Share my story

The digene HC2 HPV Test is the most sensitive HPV test on the market

When it comes to cervical cancer screening, sensitivity is the key. Early detection allows you to make more thorough and informed patient management decisions. The digene HC2 HPV Test is:

  • Internationally recognized as the gold standard
  • The most validated HPV test on the market
  • The only HPV assay that provides complete genome coverage

Additionally, the digene HC2 HPV Test:

  • Has sold 100,000,000+ tests worldwide
  • Has 2000+ publications
  • Is used in 40+ countries

Get the latest statistics on cervical cancer

Download the infographic

The development of cervical cancer screening

The Papanicolaou (Pap) Test

  • Introduced by George Papanicolaou in 1949
  • A significant step that had a tremendous impact in developed countries
  • Limitations for large-scale implementation in LMIC

HPV as cause of cervical cancer

  • Discovered by Professor Harald zur Hausen in the early 1980’s
  • HPV-16 and HPV-18 DNA was found in cervical tumor samples
  • Discovery recognized for a Nobel Prize in Medicine in 2008

The digene HC2 HPV Test

  • First HPV DNA test approved by the FDA
  • Provided clinicians a new tool for cervical cancer screening
  • Over 100 million tests performed

Screening guidelines change

  • Guidelines now recommend HPV testing, including the digene HC2 Test
  • Increased adoption of HPV testing worldwide
  • HPV test is on the WHO List of Essential In Vitro Diagnostics

*Testimonials will be reviewed by QIAGEN and uploaded upon completion of the electronic release form by the customer. An additional release form is required if the customer uses their employer’s name in the testimonial. QIAGEN reserves the right to upload testimonials to the website. T-shirts are available while supplies last and are limited to one T-shirt per person. Offer not available in all countries. Void where prohibited and may be subjected to reporting as dictated by the US Sunshine Act laws.
This paper does not represent approved claims for the product.
**Phone chargers are available while supplies last and are limited to one charger per person. Offer not available in all countries. Void where prohibited and may be subjected to reporting as dictated by the US Sunshine Act laws.
Social Sharing